LDS/Medical Tests/Aldosterone, Urine

Aldosterone, Urine

Aldosterone is a mineralocorticoid hormone produced in the zona glomerulosa of the adrenal cortex. It plays an important role in maintaining normal sodium and potassium concentrations in blood and in controlling blood volume and blood pressure. Secretion of aldosterone is controlled by the renin-angiotensin system. Renin is released from the kidneys when there is a drop in blood pressure, a decrease in sodium concentration, or an increase in potassium concentration. Renin cleaves the blood protein angiotensinogen to form angiotensin I, which is then converted by a second enzyme to angiotensin II. Angiotensin II causes blood vessels to constrict, and it stimulates the production of aldosterone. The overall effect is to raise blood pressure and keep sodium and potassium at normal levels by acting on the distal tubules and collecting ducts of the kidney to cause the conservation of sodium, secretion of potassium, increased water retention, and increased blood pressure.

A variety of conditions can lead to overproduction (hyperaldosteronism) or underproduction (hypoaldosteronism) of aldosterone. Because renin and aldosterone are so closely related, both substances are often tested together to identify the cause of an abnormal aldosterone.

A plasma aldosterone and a plasma renin are usually ordered together when a patient has high blood pressure and a low potassium. Even if potassium is normal, testing may be done if typical medications do not control the high blood pressure or if hypertension develops at an early age. Primary aldosteronism is a potentially curable form of hypertension, so it is important to detect and treat it properly. Aldosterone levels are occasionally ordered, along with other tests, when a doctor suspects that a patient has adrenal insufficiency (see interpretation).

  • In diagnosis of primary hyperaldosteronism (PH), also known as Conn's syndrome, which causes high blood pressure
  • Diagnosis of secondary hyperaldosteronism related to cardiovascular or kidney diseases such as congestive heart failure, cirrhosis, and kidney disease
  • Diagnosis of hypoaldosteronism, primary or secondary
  • Monitor effectiveness of treatment
  • Evaluation of adrenal function

Increased in:

  • Primary and secondary hyperaldosteronism
  • Some patients with essential hypertension

Decreased in:

  • Primary hypoaldosteronism (e.g., 18-hydroxylase deficiency)
  • Secondary hypoaldosteronism (hyporeninemic hypoaldosteronism)

A plasma aldosterone and a plasma renin are usually ordered together when a patient has high blood pressure and low potassium. Below is a summary of aldosterone, cortisol and renin levels in major adrenal related deficiencies.

Disease Aldosterone Cortisol Renin
Primary hyperaldosteronism High Normal Low
Secondary hyperaldosteronism High Normal High
Cushing’s syndrome Low–normal High Low
Adrenal insufficiency (Addison’s disease) Low Low High

Urinary aldosterone levels less than 14 microgram/24 hrs while consuming a high sodium diet rules out primary aldosteronism, except the type alleviated by glucocorticoids.

Age Group Reference Range (µg/24 hours) SI Units (nmol/day)
0–30 days 0.7–11.0 1.94–30.5
1–11 months 0.7–22.0 1.94–61.0
>12 months 2.0–16.0 5.5–44.3

Note: measure also the sodium in the urine specimen.

Two-site immunoradiometric assays, chemiluminescence immunoassay, ELISA, radioimmunoassay

Urine (Random or 24 hour). 

Stability

  • Ambient: Unacceptable
  • Refrigerated:  7 days
  • Frozen: 60 days
Tests to evaluate for Primary Aldosteronism usually include: serum sodium and potassium, Urinary potassium, Plasma renin activity (PRA), Plasma Aldosterone/Renin Activity Ratio, Plasma aldosterone, Urine aldosterone following a high sodium diet, Plasma aldosterone following intravenous saline infusion, Plasma aldosterone after ACE inhibitor. Other tests include: Renin Direct, Cortisol, Electrolyte Panel, Comprehensive Metabolic Panel, CT/ MRI, Adrenal Vein Sampling, Liver function studies.
2-3 days up to 7 after receipt in performing laboratory.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • J Hypertens 2006;24:737. [PMID: 16531803]
  • Endocrinol Metab Clin North Am 2002;31:619. [PMID: 12227124]
  • Clin Chem 2005;51:386. [PMID: 15681560]
  • Nat Clin Pract Nephrol 2006;2:198. [PMID: 16932426]
  • Alan Wu. Tietz Clinical Guide to Laboratory Tests, Fourth Edition. Saunders; 4 edition (June 13, 2006). ISBN-10: 0721679757